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White matterDysfunction of cerebral white matter (WM) is a potential factor underlying the neurobiology of
schizophrenia. People with 22q11 deletion syndrome have altered brain morphology and increased risk for
schizophrenia, therefore decreased WM integrity may be related to schizophrenia in 22q11DS. We measured
fractional anisotropy (FA) and WM volume in 27 adults with 22q11DS with schizophrenia (n=12, 22q11DS
SCZ+) andwithout schizophrenia (n=15, 22q11DS SCZ−), 12 individuals with idiopathic schizophrenia and
31 age-matched healthy controls. We found widespread decreased WM volume in posterior and temporal
brain areas and decreased FA in areas of the frontal cortex in the whole 22q11DS group compared to healthy
controls. In 22q11DS SCZ+ compromisedWM integrity included inferior frontal areas of parietal and occipital
lobe. Idiopathic schizophrenia patients showed decreased FA in inferior frontal and insular regions compared
to healthy controls. We found noWM alterations in 22q11DS SCZ+ vs. 22q11DS SCZ−. However, there was a
negative correlation between FA and PANSS scores (Positive and Negative Symptom Scale) in the whole
22q11DS group in the inferior frontal, cingulate, insular and temporal areas. This is the ﬁrst study to
investigate WM integrity in adults with 22q11DS. Our results suggest that pervasive WM dysfunction is
intrinsic to 22q11DS and that psychotic development in adults with 22q11DS involves similar brain areas as
seen in schizophrenia in the general population.re, University of Amsterdam,
sterdam, The Netherlands.
lves).
vier OA license. © 2011 Elsevier B.V. Open access under the Elsevier OA license. 1. Introduction
22q11 deletion syndrome (22q11DS) or velocardiofacial syndrome
is caused by an interstitial deletion at the q11.2 locus of chromosome22
(Carlson et al., 1997). This genetic disorder results in a variable clinical
phenotype comprising somatic, cognitive, behavioral and psychiatric
disorders, including schizophrenia-like psychosis (Murphy et al., 1999;
Shprintzen, 2008). Therefore, the 22q11DSmayprovidevaluable insight
into the neuropathology associated with schizophrenia.
Brain imaging studies in 22q11DS have focused on identifying
alterations in neural anatomy that might contribute to observed
behavioral and psychiatric phenotypes associated with the syndrome.
Several structural magnetic resonance imaging (MRI) studies have
reported similarities in brain morphology in people with 22q11DS and
in people with schizophrenia. These ﬁndings include enlarged corpus
callosum and lateral ventricles and reduced total cerebral volume andgray matter volume of the fronto-temporal lobes (Shenton et al., 2001;
Tan et al., 2009).
Over the last decade there has been growing evidence for the
involvement of cerebral white matter (WM) in the psychopathology
of schizophrenia (Walterfang et al., 2006; Konrad andWinterer, 2008;
Connor et al., 2010). Volumetric MRI studies have found decreased
WM volume in the corpus callosum, frontal and temporal lobes in
schizophrenia (Kubicki et al., 2005; Williams, 2008). In 22q11DS
reducedWM volume seems to occur early in life and in the absence of
psychosis. Volumetric studies in children with 22q11DS report
reduction of WM in frontal, parietal and temporal regions (Eliez
et al., 2000, 2001; Kates et al., 2001; Simon et al., 2005; Campbell et al.,
2006; Baker et al., 2011). However, a recent longitudinal study has
shown increased WM volume in adolescents with 22q11DS (Kates
et al., 2011). Moreover, a widespread loss of WM volume has been
associated with the development of schizophrenia in adults with
22q11DS (van Amelsvoort et al., 2004).
Diffusion tensor imaging (DTI) is a neuroimaging technique
employed for investigation of integrity ofWM ﬁbers beyond volumetric
measurements. Brain WM consists of bundles of myelinated axons
connecting several graymatter areas of the brain. Integrity ofWM ﬁbers
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(Takeuchi et al., 2010). Therefore, disruption of WM integrity may
account for some of the cognitive deﬁcits and psychotic symptoms seen
in schizophrenia and in 22q11DS.
DTI allows for quantiﬁcation of diffusion of water molecules
(expressed as fractional anisotropy (FA)) within axons (Basser, 1995).
Lower FA is indicates lower connectivity or integrity of WM ﬁbers
(Beaulieu, 2002). DTI studies in schizophrenia reported reduced FA in
frontal and temporal brain regions, in commissural and association
WM ﬁbers (Kanaan et al., 2005; Kubicki et al., 2007; Konrad et al.,
2009; Peters et al., 2010). The few DTI studies that have been
conducted in people with 22q11DS have been done in children and
adolescents. These studies reported reduced FA in areas of the frontal,
parietal and temporal lobes (Barnea-Goraly et al., 2003; Simon et al.,
2005; Sundram et al., 2010) and clusters of increased FA from the
posterior corpus callosum to the occipital lobes (Barnea-Goraly et al.,
2003). Increased FA was also found in frontal and parietal clusters and
in areas of the anterior to posterior cingulate gyrus, extending to the
posterior corpus callosum and in the right inferior parietal lobe
(Simon et al., 2005, 2008). Moreover, FA reductions in the left inferior
parietal lobe correlated with poor arithmetic task performance
(Barnea-Goraly et al., 2005). These ﬁndings suggest disturbed
functional development of the brain in youth with 22q11DS. During
transition to adulthood progressive and abnormal changes in brain
structure in 22q11DS may take place that probably is critical for the
development of schizophrenia. Furthermore, brain changes in
22q11DS patients with schizophrenia may develop in a distinctive
manner compared to 22q11DS without schizophrenia with particular
implication of WM (van Amelsvoort et al., 2004).
The aim of the study was to enhance our understanding of WM
integrity in adults with 22q11DS and its associationwith symptoms of
schizophrenia. Based on the above ﬁndings, we expected altered WM
integrity in posterior and frontal brain areas in adults with 22q11DS.
Moreover, we hypothesize that in 22q11DS with schizophrenia
changes in FA would extend from parietal to fronto-temporal regions,
perhaps showing similar FA aberrations as in idiopathic schizophre-
nia. In addition, we explored whether FA and WM volume
differentiates between 22q11DS patients with and without
schizophrenia.
2. Methods
2.1. Subjects
We included 27 adults with 22q11DS (mean±SD) (22q11DS SCZ+
n=12, age 31.17±6.78; 22q11DS SCZ− n=15, age 28.80±8.56), 31
healthy controls (HC age 32.35±9.74) and 12 males with idiopathic
schizophrenia (age 23.33±3.47).
Individuals with 22q11DS were recruited through the Dutch
22q11DS family association and several Dutch Clinical Genetics
Centres. Individuals with idiopathic schizophrenia were recruited
from the Adolescent Clinic of the Department of Psychiatry, Academic
Medical Centre, University of Amsterdam (AMC). Healthy volunteers
were recruited by local advertisement. The study was conducted at
the Department of Psychiatry, Academic Medical Centre Amsterdam,
The Netherlands and was approved by the local Medical Ethics
Committee. All participants were capable of giving written informed
consent and did so, after receiving full information on the study.
All individuals with 22q11DS were interviewed by a physician
using semi-structured psychiatric interview. None of the healthy
participants had a history of psychiatric disorders, medical conditions
affecting brain function, substance or alcohol abuse and they were not
using any medication at the time of testing. The 22q11DS group was
subdivided into 2 groups: those who were fulﬁlling DSM-IV criteria
for schizophrenia (22q11DS SCZ+) all taking antipsychotic medica-
tion and duration of illness N1 year) and those who did not have apsychiatric history (22q11DS SCZ−) and were neuroleptic and
psychostimulant na ve. Clinical diagnoses of individuals with idio-
pathic schizophrenia were made according to the DSM-IV criteria by
two psychiatrists independent of the study. Idiopathic schizophrenia
patients were receiving care at the psychiatric open-ward inpatient
and day care units of AMC, and were all medicated at the time of
testing.
The Positive and Negative Symptom Scale (PANSS) (Kay et al.,
1987) was used to assess positive, negative and general psychopa-
thology in the patient groups. In addition, for assessment of
intelligence quotient (IQ) we used the shortened Dutch version of
the Wechsler Adult Intelligence Scale (WAIS-III NL) consisting of 5
subtests: vocabulary, comprehension, similarities (verbal IQ), block
design, and object assembly (performance IQ) (Canavan et al., 1986;
Wechsler, 1997).
2.2. MRI data acquisition
Whole brain magnetic resonance image (MRI) acquisition took
place at the Department of Radiology (Academic Medical Centre
Amsterdam, The Netherlands) using a 3 Tesla Intera MRI system
(Philips, Best, The Netherlands) equippedwith a 6 channel sense head
coil.
DTI data were acquired using 3D multi-slice spin echo single shot
echo-planar imaging with a repetition time (TR)/echo time (TE)
4834/94 diffusion sensitivities of b=0 and b=1000 s/mm2; 32
diffusion gradient directions; 38 continuous (no inter-slice gap)
slices, slice thickness 3 mm, 230×230 mm FOV; acquisition matrix
112×109; acquisition voxel size 2.05×2.10×3 mm.
For anatomical localization transversal high-resolution structural
3D T1-weighted sequences; full head coverage; TR/TE of 9.8/4.6 ms;
axial orientation; 120 continuous (no inter-slice gap) slices; slice
thickness 1.2 mm; ﬂip angle 8°; 224×117 mm ﬁeld of view (FOV);
acquisition matrix 192×152×120; acquisition voxel size 1.17×
1.17×1.20 mm.
2.3. MRI data processing
All data were processed using SPM8 (Statistical Parametric
Mapping software, version 8, http://www.ﬁl.ion.ucl.ac.uk/spm) and
VBM8 (Voxel-Based Morphometry toolbox for SPM8) toolboxes on
Matlab R2007a platform (The MathWorks Inc., USA version 7.4). To
register the MRI images (T-1 weighed volumetric images and FA), we
used the Diffeomorphic Anatomical Registration using Exponentiated
Lie algebra algorithm (DARTEL) (Ashburner, 2007; Ashburner and
Friston, 2009; Klein et al., 2009) tools integrated in both SPM8 and
VBM8. Because DARTEL produces a more accurate registration, it
improves the sensitivity of ﬁnding differences and localizing differ-
ences between groups in the concentration of WM. In order to
normalize images to MNI space, an already existing DARTEL template
in MNI space was used. This template was derived from 550 healthy
European subjects of average age in IXI-database (http://www.brain-
development.org). Therefore, no study-speciﬁc DARTEL template
was created. All images were ﬁrst converted from scanner-speciﬁc
PAR/REC format to the NIFTI format.
T1-weighed images were checked for scanner artifacts and gross
anatomical abnormalities. The individual T1 images were subse-
quently rigidly aligned to a pre-existing T1 template in MNI space.
Following, individual probabilistic WM images were extracted using
the VBM8 toolbox (http://dbm.neuro.uni-jena.de/vbm.html). Trans-
formation parameters (ﬂow-ﬁelds) and Jacobian determinants were
calculated. The ﬂow ﬁelds were applied to anatomically warp the
individual WM probabilistic images to the DARTEL template and the
Jacobian determinants were applied to modulate the warped images
to account for local volume changes. The WM images were smoothed
Table 1
Demographic and clinical variables (mean±SD).
22q11DS
SCZ+
22q11DS
SCZ−
Idiopathic
SCZ
Healthy
Controls
N (male/female) 7 m/5f 6 m/9f 12 m 17 m/14f
Age 31.17±6.78 28.80±8.56 23.33±3.47 32.35±9.74
IQ 67.50±16.93 78.67±7.56 88.50±15.28 104.13±12.53
PANSS positive
scale
11.00±3.55 7.46±0.78 12.67±2.93
PANSS negative
scale
17.64±7.42 10.69±2.63 13.33±4.92
PANSS general
psychopathology
scale
32.18±10.39 22.15±4.04 26.17±5.42
Total PANSS 60.82±18.26 40.31±5.76 52.17±8.66
PANSS: Positive and Negative Symptom Scale.
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(FWHM).
The DTI datawere post processed using Philips Achieva software to
create FA value maps. Image distortions in DTI data induced by eddy
currents and head motion were corrected by applying a full afﬁne
alignment of each diffusion image to the mean no-diffusion-weighted
image. The FA images were rigidly co-registered to the (segmented)
WM image of the corresponding subject. As the FA closely resembles
theWM images, and is in register with them, the ﬂow ﬁelds that were
used to warpWM to DARTEL space were also applied to the FA images
in order to warp them directly into MNI space. Finally as with the
VBM, the FA images were smoothed with a 12 mm FWHM Gaussian
ﬁlter.
3. Statistical analysis
3.1. Demographic data
Group differences in age, IQ and PANSS were examined using
analysis of variance (ANOVA). Group differences in gender were tested
with Chi-square tests. Compiled data are expressed asmean±SD. Level
of statistical signiﬁcance was deﬁned as Pb0.05 (two tailed). Statistical
analyses were performed with SPSS, release 16.0.2 for Windows (SPSS
Inc., Chicago, IL, USA).
3.2. Voxel-based analysis of fractional anisotropy and white matter
volume
To test for FA and WM volume differences between 22q11DS
patients, idiopathic schizophrenia and controls voxel-wise statistics
were performed twice using independent-sample t-tests implemented
in the general linearmodel approachof SPM8. In theﬁrstmodelwithout
covariates, the analysis was conducted using t-contrasts “1 −1” for
group ANB and “−1 1” for group AbB. Group comparisons were
corrected for multiple comparisons using family wise error correction
(FWEcor) at cluster level Pb0.05. In the second model, these same
analyses for 22q11DS were performed including IQ as nuisance
covariate, which means that all effects that can be explained by IQ
were removed from the data. For the idiopathic schizophrenia group,
analyses were performed including IQ, age and gender as covariate.
Voxel coordinates are given as an indication of location in a
standardized brain. Additionally, resulting cluster maps of FA images
were overlaid for visualization. Voxels and clusters were localized in
Montreal Neurological Institute (MNI) space and transformed into
Talairach and Tournoux coordinates. To further localize signiﬁcant voxel
clusters brain ﬁbers up-to-date atlases were consulted (Talairach and
Tournoux, 1988; Brett et al., 2002; Mori et al., 2005).
4. Results
4.1. Demographics
Demographics are displayed in Table 1. 22q11DS and healthy
controls did not differ with regard to age (HC 32.35±9.74, 22q11DS
SCZ+ 31.17±6.78, 22q11DS SCZ− 28.80±8.56, P=0.99). The group
of idiopathic schizophrenia patients was signiﬁcantly younger than
healthy controls (23.33±3.47; P=0.012). Sex was signiﬁcantly
different between the groups; idiopathic schizophrenia group was
composed exclusively of males (HC 17 m/14f, 22q11DS SCZ+ 7 m/5f,
22q11DS SCZ− 6 m/9f, idiopathic schizophrenia 12 m; P=0.013).
Patients had a lower total IQ than healthy controls (HC 104.13±
12.54, 22q11DS SCZ+ 67.50±16.93, 22q11DS SCZ− 78.67±7.57,
idiopathic schizophrenia 88.50±15.28; Pb0.001). Total IQ was signif-
icantly different between HC vs. 22q11DS SCZ+ (Pb0.001), HC vs.
22q11DS SCZ− (Pb0.001) and HC vs. idiopathic schizophrenia
(P=0.027). Total IQ was also signiﬁcantly different between idiopathicschizophrenia vs. 22q11DS SCZ+ (P=0.027) and 22q11DS SCZ+ vs.
22q11DS SCZ− (P=0.036).
The mean scores on the PANSS subscales were signiﬁcantly different
between the patient groups (Pb0.05). Scores on positive symptoms
(P=0.007), negative symptoms (P=0.008) and general psychopathol-
ogy (P=0.004)were signiﬁcantly higher in 22q11DS SCZ+vs. 22q11DS
SCZ−. In addition, positive symptoms scoreswere signiﬁcantly higher in
idiopathic schizophrenia vs. 22q11DS SCZ− (P=0.001). The scores of
total PANSS symptomswerehigher in22q11DSSCZ+vs. 22q11DSSCZ−
(P=0.001) and in idiopathic schizophrenia vs. 22q11DS SCZ−
(P=0.050). Therewere no signiﬁcant differences in the PANSS subscales
between 22q11DS SCZ+ and idiopathic schizophrenia.
4.2. Fractional anisotropy
FA results including brain localization, voxel coordinates and P
values for patient-controls and patient-patient comparisons are
displayed in Table 2.
4.2.1. Patient–control and patient–patient comparisons—model without
covariates
The whole 22q11DS group compared to healthy controls had
signiﬁcantly decreased FA in the right hemisphere in the pre-central
and post-central areas (FWEcor=0.021) and frontal sub-gyral
(FWEcor=0.025), and signiﬁcantly increased FA in the anterior
cingulate (bilaterally) (FWEcor=0.002).
There was no decreased FA in 22q11DS SCZ+ patients compared
to healthy controls surviving the correction for multiple comparisons
but signiﬁcantly increased FA in the left anterior cingulate and left
frontal sub-gyral area (FWEcor=0.025).
There was no decreased FA in 22q11DS SCZ− patients compared
to healthy controls surviving the correction for multiple comparisons
but signiﬁcantly increased FA in the right frontal sub-gyral
(FWEcor=0.006).
There were no signiﬁcant differences in FA in idiopathic SCZ
patients compared to healthy controls surviving the correction for
multiple comparisons. Also, there were no signiﬁcant differences in FA
in idiopathic SCZ patients compared to 22q11DS SCZ+ and in
idiopathic SCZ compared to 22q11DS SCZ−.
4.2.2. Patient–control and patient–patient comparisons — model with
covariates
The whole 22q11DS group compared to healthy controls had
signiﬁcantly decreased FA in the pre-central and post-central areas
(bilaterally), in the right parietal sub-gyral (FWEcorb0.001), right
superior frontal area (FWEcorb0.001) and in the parahippocampal
area (bilaterally) (FWEcor=0.017).
22q11DS SCZ+ patients compared to healthy controls had signiﬁ-
cantly decreased FA in several areas of the frontal lobes bilaterally,
Table 2
Fractional anisotropy: regions of signiﬁcant differences between patients and healthy controls.
Cluster size Brain area P
value
T & T Z
value
Tract
x y z
A. Model without covariates
22q11DS Patients vs. HC
Decreased FA
1151 R frontal precentral 0.021 54 −3 31 4.30 slf
R parietal postcentral 44 −19 42 4.23 slf
2778 R frontal sub-gyral 0.025 44 18 18 3.83
Increased FA
2155 L anterior cingulate 0.002 −9 38 9 4.39 cg/cc/gcc
L frontal sub-gyral 15 41 6 3.86 cg/cc
R anterior cingulate −21 27 27 3.55 acr
22q11DS SCZ− vs. HC
Increased FA
3872 R frontal sub-gyral 0.006 26 26 19 3.53 cg/cc/acr
22q11DS SCZ+ vs. HC
Increased FA
2660 L anterior cingulate 0.025 −11 39 7 4.01 cg/cc
L frontal sub-gyral −20 24 28 3.69 cg/cc/acr
B. Model with covariates
22q11DS Patients vs. HC
Decreased FA
5903 R superior frontal 0.001 21 8 56 4.14 cc/cg
2317 R frontal precentral 0.001 47 −4 43 3.83 slf
R parietal sub-gyral 38 −31 43 3.62 slf
1679 L frontal precentral 0.005 −30 −13 54 3.84 slf
L parietal postcentral −45 −17 43 3.79 slf
1252 L parahippocampal 0.016 −28 −36 −5 3.20 ilf
1229 R parahippocampal 0.017 23 −19 −14 3.25 unc/ilf
22q11DS SCZ− vs. HC
Decreased FA
3196 L frontal precentral 0.000 −27 −10 56 4.11 slf
L middle frontal −26 3 57 4.15 slf/cc
3869 R frontal precentral 0.000 36 −18 55 4.58 slf
R middle frontal 23 2 61 4.14 slf/cc
R superior parietal 23 −61 56 4.13 slf
22q11DS SCZ+ vs. HC
Decreased FA
936 R frontal precentral 0.032 33 −9 49 4.16 slf
1841 L frontal precentral 0.003 −32 −16 54 4.01 slf
L parietal postcentral −41 −19 42 3.91 slf
4808 R parietal precuneus 0.001 27 −48 49 3.79 pcr
R medial frontal 21 5 61 3.54 scr
5240 L inferior frontal 0.001 −35 26 −11 3.61 unc/ifo
R inferior frontal 27 11 −18 3.41 unc/ifo
R middle frontal 16 39 −20 3.37 ifo/cc/unc
7911 L middle occipital 0.001 −39 −78 16 4.00 ifo/ilf/ptr
Idiopathic SCZ vs. HC
Decreased FA
5637 R frontal sub-gyral 0.003 33 32 3 3.85 ifo/cc/unc
R insula 44 5 12 3.76 slf
R inferior frontal 44 27 −5 3.65 unc/ifo
PFWEb0.05 corrected for multiple comparissons; L: left; R: right; T&T: Talairach and Tournoux coordinates of most signiﬁcant voxels slf:superior longitudinal fascicuulus; cg:
cingulum; cc: corpus callosum; acr: anterior corona radiata; unc: uncinate fasciculus; ifo: inferior fronto-occipital fasciculus; pcr: posterior corona radiata; scr: superior corona
radiata; ilf: inferior longitudinal fasciculus; ptr: posterior thalamic radiation; scc: splenium of corpus callosum.
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including parietal and occipital regions (FWEcorb0.001) (Fig. 1).
22q11DS SCZ− patients compared to healthy controls had
signiﬁcantly decreased FA in the precentral areas and the middle
frontal areas (bilaterally) and in the right superior parietal sub-gyral
area (FWEcorb0.001). There was no signiﬁcant increased FA in any of
the above comparisons.
Therewasno signiﬁcantdecreasedor increasedFA in 22q11DSSCZ+
patients compared to 22q11DS SCZ− patients.
Idiopathic SCZ patients compared to healthy controls had
signiﬁcantly decreased FA in the right frontal sub-gyral area, right
insula and right inferior frontal area (FWEcorb0.002).
There were no signiﬁcant differences in FA in idiopathic SCZ
patients compared to 22q11DS SCZ+ and in idiopathic SCZ compared
to 22q11DS SCZ−.4.3. Correlation FA and PANSS in 22q11DS
In the whole 22q11DS group FA was negatively correlated with
scores of the positive, negative and total symptoms of the PANSS scale.
Table 3 shows the correlations between FA in the whole 22q11DS
group and the PANSS including brain localization, voxel coordinates
and P values.
Severity of positive symptoms was associated with signiﬁcantly
decreased FA in areas of the frontal (bilaterally) and right temporal areas
(FWEcorb0.005) (Fig. 2). Severity of negative symptoms associatedwith
decreased FA in areas of the left frontal (FWEcorb0.001) and left
temporal lobe (FWEcorb0.005). Scores of total PANSS including general
psychopathology were associated with decreased FA in areas of the left
temporal lobe and frontal lobe (bilaterally) (FWEcorb0.001) and left
insula (FWEcor=0.008).
Fig. 1. Brain areas of decreased fractional anisotropy in 22q11DS patients with schizophrenia compared to healthy controls.
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in idiopathic SCZ patients.
4.4. White matter volume
We foundwidespreadWMdecreases bilaterally in posterior areas in
22q11DS. WM results including brain localization, voxel coordinates
and P values for patient–controls and patient–patient comparisons are
displayed in Table 4.
4.4.1. Patient–control and patient–patient comparisons—model without
covariates
The whole 22q11DS patients compared to healthy controls had
signiﬁcantly decreased WM volume in the occipital lobe (bilaterally),
left middle frontal lobe and parahippocampal cortex and right pons
(FWEcorb0.001), left parietal subgyral and precuneus (FWEcor=0.007).
22q11DS SCZ+ patients compared to healthy controls had
signiﬁcantly decreased WM volume in the occipital lobe (bilaterally),
pons (bilaterally) and left temporal and parahippocampal lobe
(FWEcorb0.001).22q11DS SCZ− patients compared to healthy controls had
signiﬁcantly decreased WM volume in the occipital lobe (bilaterally)
and in the right pons (FWEcorb0.001).
There was no signiﬁcant decreased or increased WM volume in
22q11DS SCZ+ patients compared to 22q11DS SCZ− patients.
There were no signiﬁcant differences in WM volume in idiopathic
SCZ compared to healthy controls. Also, the comparisons of WM
volume in idiopathic SCZ vs. 22q11DS SCZ+ and idiopathic SCZ vs.
22q11DS SCZ− showed no signiﬁcant differences.
4.4.2. Patient–control and patient–patient comparisons — model with
covariates
The whole 22q11DS patients compared to healthy controls had
signiﬁcantly decreased WM volume in the cuneus (bilaterally)
(FWEcorb0.001), right superior temporal lobe (FWEcor=0.001) and
in the post-central areas (bilaterally) (FWEcor=0.034).
22q11DS SCZ+ patients compared to healthy controls had
signiﬁcantly decreased WM volume in the occipital lobe (bilaterally),
right temporal sub-gyral (FWEcorb0.001) and in the right pons
(FWEcorb0.032).
Table 3
Regions of signiﬁcant negative correlation between FA and PANSS in the whole
22q11DS group.
Cluster
size
Brain area P
value
T & T Z
value
Tract
x y z
Positive symptoms
1632 R inferior frontal 0.002 30 18 −14 5.09 unc
R superior temporal 35 6 −21 4.06 unc/ilf
R inferior temporal 50 −5 −27 3.83 unc/ilf
1328 L inferior frontal 0.006 −24 26 −8 4.16 unc/ilf
L frontal sub-gyral −12 33 −14 3.83 unc/ifo/cc
L frontal precentral −33 −21 55 3.57 scr
Negative symptoms
2456 L medial frontal gyrus 0.000 −8 −1 61 4.90 scr
L frontal sub-gyral −15 −22 43 4.59 scr
1224 L temporal sub-gyral 0.008 −47 −16 −20 4.00 ilf
L pons 0 −31 −24 3.83 scp
Total psychopathology
3890 L temporal sub-gyral 0.000 −50 −21 −18 4.81 ilf
1907 L medial frontal gyrus 0.001 −5 −1 59 4.52 scr
L cingulate −9 −4 43 4.35 cg
1220 L Sub-lobar Insula 0.008 35 19 5 4.40 unc/ifo
R inferior frontal 30 22 −10 3.90 unc/ifo
R frontal sub-gyral 12 16 −10 3.68 unc/ifo
PFWEb0.05 corrected for multiple comparissons; L: left; R:right; T&T: Talairach and
Tournoux coordinates of most signiﬁcant voxels; unc:uncinate fasciculus; ilf:inferior
longitudinal fasciculus; ifo:inferior fronto-occipital fasciculus; cc:corpus callosum; scr:
superior corona radiata; scp:superior cerebellar penducle; cg:cingulum.
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niﬁcantly decreased WM volume in the occipital lobe (bilaterally)
(FWEcorb0.001), right superior temporal and parahippocampal
areas (FWEcor=0.003), right parietal post-central and precuneus
(FWEcor=0.005) and in the right pons (FWEcor=0.020).
There was no signiﬁcant decreased or increased WM volume in
22q11DS SCZ+ patients compared to 22q11DS SCZ− patients.
There were no signiﬁcant differences in WM volume in idiopathic
SCZ compared to healthy controls. There were no signiﬁcant
differences in WM volume in idiopathic schizophrenia compared to
22q11DS SCZ+ patients.
Idiopathic SCZ patients compared to 22q11DS SCZ− patients had
signiﬁcantly increased WM volume in the occipital cuneus (bilaterally)
(FWEcorb0.001).
5. Discussion
This is the ﬁrst DTI study combinedwith VBM to investigateWM in
adults with 22q11DS and its relation with schizophrenia. The results
of this study show that reduced WM volume, particularly in posterior
brain regions, is a typical feature of 22q11DS. Our ﬁndings conﬁrmed
the hypothesis of altered WM integrity posterior and frontal brain
areas in adults with 22q11DS compared to healthy controls. Also, in
line with our expectations we found decreased FA in posterior brain
areas and widespread decreased FA in frontal lobes in 22q11DS SCZ+
compared to healthy controls. Particularly, ﬁndings in 22q11DS SCZ+
vs. controls resemble comparisons between idiopathic schizophrenia
vs. controls, with FA reductions encompassing inferior frontal WM.
Contrary to our expectations, we found no areas of increased or
decreased FA andWM volume that could differentiate 22q11DS SCZ+
from 22q11DS SCZ−. In the whole 22q11DS group, scores of positive
and negative symptoms were associated with reduced FA in areas
previously implicated in schizophrenia mainly in frontal, cingulate,
insula and temporal areas.
Earlier studies of brain volume in 22q11DS have proposed that
WM alterations in 22q11DS affect particularly posterior areas of the
brain (Eliez et al., 2000; Kates et al., 2001; Campbell et al., 2006).
Similarly, we have foundWM volumes decreased in occipital, parietaland temporal brain areas in the whole 22q11DS and in the patients
subgroups (22q11DS SCZ+, 22q11DS SCZ−) compared to healthy
controls. However, WM alterations in adults with 22q11DS are not
limited to the posterior brain since our FA results showed decreased
values in several brain regions including frontal lobes. The FA
reductions that we observed in the whole 22q11DS sample are
localized in WM areas encompassing ﬁbers of the cingulum and
corpus callosum, the superior longitudinal fasciculus, the inferior
longitudinal and the uncinate fasciculus. These ﬁndings of decreased
FA in 22q11DS are consistent with previous DTI studies investigating
WM integrity in young people with 22q11DS (Barnea-Goraly et al.,
2003; Simon et al., 2005; Sundram et al., 2010). Thus, alterations in
fronto-parietal and fronto-temporal WM ﬁbers may disrupt signal
transmission and brain connectivity in adults with 22q11DS conse-
quently implicating altered brain function and behavior.
Increased FA has been reportedmainly in children and adolescents
with 22q11DS in posterior areas of the brain (Barnea-Goraly et al.,
2003; Simon et al., 2005, 2008). We found increased FA in the whole
group of adults with 22q11DS in frontal and parietal areas encom-
passing WM ﬁbers of the corpus callosum, cingulum, and from
anterior to posterior corona radiate. However, in line with Sundram
et al. (2010) the statistical signiﬁcance of increased FA disappeared
after covarying for IQ. The ﬁndings of increased FA, perhaps related to
increased neuronal density or rearrangements of ﬁber organization,
may be speciﬁc to the abnormal development of the brain in 22q11DS
during childhood. Disproportional increases in WM volume and FA
have also been reported in children with autism spectrum disorder
(Ben et al., 2007; Cheng et al., 2010) and in young-onset schizophre-
nia (Douaud et al., 2009). However, increases in FA may be also due to
the confounding effects of IQ. Earlier FA studies in children with
22q11DS did not control for cognitive disability (Barnea-Goraly et al.,
2003; Simon et al., 2005, 2008), which is a well established feature of
22q11DS. Since we controlled for IQ, our ﬁndings of FA decreases
instead of increases may be accurately attributed to 22q11DS.
Moreover, a recent study showed reduction of total WM volume in
adolescents with 22q11DS compared to IQ-matched controls suggest-
ing that dysfunction of WM in 22q11DS is independent of IQ and
inherent to 22q11DS (Baker et al., 2011).
For a better understanding of WM integrity in 22q11DS and its
association with schizophrenia we split the 22q11DS group in 22q11DS
SCZ+ and 22q11DS SCZ−. The comparison of the 22q11DS subgroups
showed no differences in FA or WM volumes. Narrowing our
comparison down to each 22q11DS subgroup vs. healthy individuals
we observed similar areas of decreasedWMvolume in occipital lobes in
both 22q11DS SCZ+ and 22q11DS SCZ−. But in 22q11DS SCZ− WM
volume was also decreased in parietal brain regions. Moreover, in
22q11DS SCZ− compared to idiopathic schizophrenia we found lower
WM volume areas of the occipital lobe. These ﬁndings indicate that
disrupted WM in posterior brain is a typical feature of 22q11DS
independent of schizophrenia. On the other hand, decreased FA in
22q11DS SCZ+ compared to healthy individuals affected mostly areas
of frontal regions. Contrary to 22q11DS SCZ−, the 22q11DS SCZ+ had
FA reductions in WM encompassing ﬁbers of the inferior fronto-
occipital, inferior longitudinal fasciculus and posterior thalamic radia-
tion, the uncinate fasciculus and anterior corpus callosum compared to
healthy controls. Furthermore, severity of symptoms of schizophrenia,
including positive, negative and total psychopathology symptoms, in
the whole 22q11DS group was associated with decreased FA in inferior
frontal, cingulate, insula and temporal areas. Disruption of these WM
networks is thought to contribute to psychotic symptoms and cognitive
deﬁcits in schizophrenia (Kubicki et al., 2007). Also, a meta-analysis of
DTI studies in schizophrenia has identiﬁed FA reductionspredominantly
inferior frontal in WM ﬁbers interconnecting the frontal lobe, thalamus
and cingulate gyrus and in a network comprising the frontal lobe, insula,
hippocampus–amygdala, temporal and occipital lobe (Ellison-Wright
and Bullmore, 2009; Peters et al., 2010). In line with these ﬁndings, we
Fig. 2. Brain areas of negative correlation between positive symptoms and fractional anisotropy in 22q11DS patients.
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ﬁbers of the inferior fronto-occipital and the uncinate fasciculus in our
group of idiopathic schizophrenia patients compared to healthy
controls. Hence, our ﬁndings in 22q11DS may indicate the involvement
of inferior frontal and temporal WM ﬁbers in the development of
schizophrenia in 22q11DS.
Several factors may contribute to disrupted WM integrity as
measured by DTI. However, the cause and mechanism of dysfunction
of WM anisotropy in people with 22q11DS is still subject to research.
Altered anisotropy as measured by DTI may reﬂect abnormal
coherence or organization of the ﬁber tracts, oligodendrocytes or
myelin disruption. In schizophrenia, integrity of WM ﬁbers has been
associated with malfunction of genes and neurotransmitters (e.g.
dopamine and glutamate) that are involved in oligodendrocyte and
myelin development (Feng, 2008; Alix and Domingues, 2011). The
same may hold for 22q11DS, particularly since people with 22q11DS
are haploinsufﬁcient for COMT and often also for PRODH (genes
involved in dopaminergic and glutamatergic neurotransmission,
respectively). Thus, haploinsufﬁciency of these, and perhaps other,
genes in 22q11DS may be implicated in WM pathology associatedwith 22q11DS. For instance, we previously reported that genetic
variation at the COMT and PRODH genes was associated with
abnormal WM volume in schizophrenia (Zinkstok et al., 2008) and
in 22q11DS (van Amelsvoort et al., 2008). In healthy children WM
anisotropy was also altered depending on genetic variation at the
COMT gene (Thomason et al., 2010). Further studies are needed to
unravel the association between genetic variations in 22q11DS,
neurotransmission and changes in anisotropy of WM.
Our study has several strengths. In contrast to earlier DTI studies in
22q11DS, this study included exclusively adults with 22q11DS
allowing us to investigate WM integrity in the mature brain. In
addition, to verify whether our ﬁndings in 22q11DS SCZ+ were
related to schizophrenia we included a group of patients with
idiopathic schizophrenia. We explored the relationship between
WM changes and schizophrenia in 22q11DS presenting data uncor-
rected but also corrected for IQ, which provides insight in the relation
between IQ and FA in 22q11DS. Furthermore the combined DTI and
VBMmeasures allowed us to extend the ﬁndings of WM alterations in
22q11DS by differentiating areas of decreasedWMvolume from those
of decreased FA.
Table 4
WM volume: regions of signiﬁcant decreases between 22q11DS patients and healthy
controls.
Cluster size Brain area P
value
T & T Z
value
x y z
A. Model without covariates
22q11DS Patients vs. HC
26155 L occipital cuneus 0.000 −12 −76 9 7.24
R occipital cuneus 17 −70 9 6.71
13265 R brainstem pons 0.000 5 −13 −26 6.04
5085 L parahippocampal 0.000 −27 −31 −3 5.13
L middle frontal −38 50 −12 4.6
2624 L parietal sub-gyral 0.007 −27 −42 51 4.1
L parietal
precuneus
−17 −54 55 3.76
22q11DS SCZ+ vs. HC
5942 L occipital cuneus 0.000 −15 −76 9 5.64
R occipital cuneus 2 −75 23 5.62
1351 R pons 0.000 3 −13 −24 4.74
L pons −8 −33 −21 4.51
951 L temporal sub-
gyral
0.000 −29 −29 −3 5.1
L parahippocampal −15 −36 −2 4.51
22q11DS SCZ− vs. HC
6114 L occipital cuneus 0.000 −12 −76 7 6.09
R occipital cuneus 17 −72 9 5.42
729 R pons 0.001 3 −13 −26 4.92
B. Model with covariates
22q11DS Patients vs. HC
9329 L occipital cuneus 0.000 −11 −76 7 5.82
R occipital cuneus 17 −70 9 5.06
2864 R brainstem pons 0.005 3 −13 −24 4.56
4405 R Superior
Temporal lobe
0.001 50 −12 2 4.56
1568 L Parietal
Postcentral lobe
0.034 −37 −19 45 4.66
3353 R Parietal
Postcentral lobe
0.003 50 −12 40 4.11
22q11DS SCZ+ vs. HC
3540 L occipital cuneus 0.002 −14 −75 6 4.24
R occipital lingual 13 −89 2 3.91
3538 R temporal sub-
gyral
0.002 35 −30 0 4.12
1557 R pons 0.032 2 −13 −23 3.69
22q11DS SCZ− vs. HC
5853 L occipital cuneus 0.000 −12 −76 7 4.43
R occipital cuneus 16 −69 13 4.12
3600 R superior
temporal
0.003 47 0 −11 4.44
R limbic
parahippocampal
12 −36 −3 3.79
3233 R parietal
postcentral
0.005 18 −40 63 4.14
R parietal
precuneus
18 −49 52 3.95
2146 R pons 0.020 2 −12 −24 4.14
22q11DS SCZ− v s .
Idiopathic SCZ
6645 R occipital cuneus 0.002 6 −85 25 5.04
L occipital cuneus −11 −73 12 4.76
PFWEb0.05 corrected for multiple comparissons; L: left; R: right; T&T: Talairach and
Tournoux coordinates of most signiﬁcant voxels.
82 F. da Silva Alves et al. / Schizophrenia Research 132 (2011) 75–83The results of the present study should be interpreted in light of
the following considerations. First, the sample size, although quite
large compared to previous studies, may have limited the power to
detect WM alterations in 22q11DS SCZ+ vs. 22q11DS SCZ−.
However, anatomical features including WM changes in 22q11DS
SCZ+ and 22q11DS SCZ− may be of subtle and overlapping nature
making discrimination between the groups difﬁcult. The inﬂuence of
medication cannot be ruled out; in schizophrenia antipsychotic
treatments may modulate structural brain changes (Keshavan et al.,1998; Thompson et al., 2009). Also the sample size of patients with
idiopathic schizophrenia may have been small to detect alterations in
WM and signiﬁcant correlation between FA and the PANSS scores. As
brain changes in WM volume in schizophrenia may occur and
progress differently across individuals over time (Olabi et al., 2011),
the relatively early stage of the illness has possibly accounted for no
changes in WM volume in our group of idiopathic schizophrenia
compared to healthy controls. Lastly, voxel based analysis of FA does
not provide information about speciﬁcity of brain ﬁbers. Fiber-
tracking and post-mortem methods are required to conﬁrm the
localization of affected WM ﬁbers.
In summary, this study reports altered WM volume and FA in
distinct areas of the brain in adults with 22q11DS. Our ﬁndings
suggest that extensive decreased WM volume in posterior brain is
intrinsic to 22q11DS and independent of the development of
schizophrenia, whereas widespread decreased FA in frontal areas
and consequently disrupted neuronal communication via WM ﬁbers
of the inferior frontal and temporal lobes may be related to psychotic
symptoms in patients with 22q11DS SCZ+. Future multimodal
imaging studies including ﬁber tracking and exploring genetic
variations involved in WM integrity will help to clarify the role of
WM in the vulnerability to schizophrenia in 22q11DS.
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